Prochlorperazine Maleate Tablet, Film Coated
Product Images NDC 67296-2099

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Maleate (NDC 67296-2099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (Image001)

This is a product description for Prochlorperazine Maleate Tablets, USP. Each film-coated tablet contains prochlorperazine maleate equivalent to prochlorperazine 5mg. The usual dosage is 10 mg to 40 mg daily. It is important to use a safety closure when dispensing this product, unless otherwise directed by a physician. The package is child-resistant and should be stored at 20° to 25°C (68° to 77°F). For complete prescribing information, refer to the accompanying package insert.*

FDA Label Image

Image003 (Image003)

Prochlorperazine tablets contain 10mg of prochlorperazine maleate and are indicated for various conditions. The usual dosage ranges from 10mg to 40mg daily. The package is child-resistant and should be stored at temperatures between 20°C to 25°C (68°F to 77°F). It is important to follow the prescribing information carefully. This product is distributed by Bionpharma Inc. from Princeton, NJ, and is made in India.*

FDA Label Image

Structure Of Prochlorperazine (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.